Amikacin - Revision history

Ostermayer at 15:09, 18 July 2025

2025-07-18T15:09:19Z

← Older revision		Revision as of 15:09, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: [[Aminoglycoside]]		*Type: [[Is DrugClass::Aminoglycoside]]
	*Dosage Forms: injectable solution		*Dosage Forms: injectable solution
	*Routes of Administration: IM, IV		*Routes of Administration: IM, IV

2019-09-19T16:46:53Z

← Older revision		Revision as of 16:46, 19 September 2019
Line 1:		Line 1:
	==General==		==General==
	*Type: Aminoglycoside		*Type: [[Aminoglycoside]]
	*Dosage Forms: injectable solution		*Dosage Forms: injectable solution
	*Routes of Administration: IM, IV		*Routes of Administration: IM, IV
Line 194:		Line 194:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

2017-10-11T18:52:06Z

modified dosage forms, added route of adminstration

← Older revision		Revision as of 18:52, 11 October 2017
Line 1:		Line 1:
	==General==		==General==
	*Type: Aminoglycoside		*Type: Aminoglycoside
	*Dosage Forms: IM, IV		*Dosage Forms: injectable solution
			*Routes of Administration: IM, IV
	*Common Trade Names: Amikin		*Common Trade Names: Amikin

2017-08-30T23:15:28Z

← Older revision		Revision as of 23:15, 30 August 2017
Line 2:		Line 2:
	*Type: Aminoglycoside		*Type: Aminoglycoside
	*Dosage Forms: IM, IV		*Dosage Forms: IM, IV
	*Common Trade Names:		*Common Trade Names: Amikin

	==Adult Dosing==		==Adult Dosing==
Line 187:		Line 187:
	===Key===		===Key===
	{{Template:Antibacterial Spectra Key}}		{{Template:Antibacterial Spectra Key}}

	==See Also==		==See Also==

2017-05-30T22:29:26Z

Text replacement - "OR" to "'''OR'''"

2016-07-19T14:24:14Z

Text replacement - "0 mg" to "0mg"

2016-07-18T20:49:59Z

Text replacement - "5 mg" to "5mg"

← Older revision		Revision as of 20:49, 18 July 2016
Line 6:		Line 6:
	==Adult Dosing==		==Adult Dosing==
	*Bacterial infections		*Bacterial infections
	**7.~~5 mg~~/kg IM/IV q12h OR		**7.5mg/kg IM/IV q12h OR
	**~~5 mg~~/kg IM/IV q8h		**5mg/kg IM/IV q8h
	*Uncomplicated UTI		*Uncomplicated UTI
	**250 mg IM BID		**250 mg IM BID
Line 14:		Line 14:
	*Neonates:		*Neonates:
	**10 mg/kg IM/IV x 1 THEN		**10 mg/kg IM/IV x 1 THEN
	**7.~~5 mg~~/kg IM/IV q12h		**7.5mg/kg IM/IV q12h
	*Infants / Children		*Infants / Children
	**~~5 mg~~/kg IM/IV q8h MAX 1.5 g/day		**5mg/kg IM/IV q8h MAX 1.5 g/day

	==Special Populations==		==Special Populations==
Line 31:		Line 31:
	***CrCl 10-29 give q18-24h		***CrCl 10-29 give q18-24h
	***CrCl <10 give q48-72h		***CrCl <10 give q48-72h
	***HD/PD start ~~5 mg~~/kg x 1, no supplement		***HD/PD start 5mg/kg x 1, no supplement
	*Hepatic Dosing Not Defined		*Hepatic Dosing Not Defined

2016-07-14T01:40:43Z

Caution if:

← Older revision		Revision as of 01:40, 14 July 2016
Line 41:		Line 41:
	*dehydration		*dehydration
	*concurrent nephrotoxic agent use		*concurrent nephrotoxic agent use
	*impaired auditory/vestibular ~~fxn~~		*impaired auditory/vestibular function
	*concurrent ototoxic/neurotoxic agent use		*concurrent ototoxic/neurotoxic agent use
	*neuromuscular disease		*neuromuscular disease

2016-07-03T10:07:27Z

Text replacement - "rxn" to "reaction"

2016-06-25T17:14:36Z

Text replacement - "==Source== <references/>" to "==References== <references/>"